Corcept Therapeutics
CORT
CORT
110 hedge funds and large institutions have $305M invested in Corcept Therapeutics in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 50 increasing their positions, 20 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
110
Holding in Top 10
2
Calls
$561K
Puts
–
Top Buyers
| 1 | +$1.62M | |
| 2 | +$1.32M | |
| 3 | +$1.15M | |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$1.12M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$1.06M |
Top Sellers
| 1 | -$3.73M | |
| 2 | -$3.63M | |
| 3 | -$824K | |
| 4 |
First Eagle Investment Management
New York
|
-$643K |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$561K |